Portfolio Update

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC All information is at 28 February 2015 and unaudited. Performance at month end with net income reinvested One Three One Since Three Five month months year 1 April years years 2012 Sterling: Share price 2.2% 8.1% 14.4% 55.9% 46.9% 69.0% Net asset value 3.4% 7.1% 13.3% 45.5% 44.2% 65.7% FTSE All-Share Total Return 3.7% 4.7% 5.6% 37.7% 36.4% 62.1% Source: BlackRock BlackRock took over the investment management of the Company with effect from 1 April 2012. At month end Sterling: Net asset value - capital only: 187.04p Net asset value - cum income*: 188.49p Share price: 184.50p Total assets (including income): £51.4m Discount to cum-income NAV: 2.1% Net Gearing: 0.2% Net yield**: 3.1% Ordinary shares in issue***: 26,229,268 Gearing range (as a % of net assets) 0-20% Ongoing charges****: 1.2% * includes net revenue of 1.45 pence per share ** based on an interim dividend of 2.20p per share and a final dividend of 3.50p per share in respect of the year ended 31 October 2014. *** excludes 6,704,664 shares held in treasury **** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 31 October 2014. Benchmark Sector Analysis Total assets (%) Support Services 11.8 Life Insurance 10.1 Tobacco 10.0 Travel & Leisure 9.1 Pharmaceuticals & Biotechnology 8.1 Banks 7.7 Oil & Gas Producers 6.6 Media 4.9 General Retailers 4.3 Mining 4.1 Non-Life Insurance 3.6 Electronic & Electrical Equipment 2.8 Food Producers 2.7 Beverages 2.6 Financial Services 2.3 Fixed Line Telecommunications 2.3 General Industrials 1.8 Household Goods & Home Construction 1.4 Industrial Engineering 0.1 Net Current Assets 3.7 Total 100.0 Ten Largest Equity Investments Company % of Total assets British American Tobacco 5.3 AstraZeneca 4.8 Imperial Tobacco Group 4.7 HSBC Holdings 4.6 Rio Tinto 4.1 Prudential 3.9 Reed Elsevier 3.8 Friends Life 3.6 Next 3.6 BP Group 3.5 Commenting on the markets, Adam Avigdori and Mark Wharrier representing the Investment Manager noted: The February performance of the UK equity market is the best monthly performance in a year, with the FTSE 100 Index reaching a new all-time high, surpassing the previous record set in 1999. The bailout negotiations for Greece dominated market sentiment with an extension being approved towards the end of the month. The Company returned 3.4%* in February, slightly underperforming the FTSE All-Share Index return of 3.7%. Over the month, the FTSE 250 Index significantly outperformed the FTSE 100 Index, returning 6.0% and 3.3% respectively. Holdings in defensive earners Reed Elsevier, AstraZeneca, Unilever, Compass Group and British American Tobacco, which have recently been strong performers, lagged the market rally in February. Being underweight in Mining and Oil & Gas also detracted from relative performance as both sectors reversed their losses from January on the back of rising commodity prices. On the positive side, our holding in Essentra was the largest positive contributor during the month after reporting strong revenue growth for 2014 and giving confidence that management can deliver on their goal to double revenues by 2020. Rio Tinto also rose after strong results, announcing a share repurchase worth $2bn and raising their dividend, reflecting the strong capital position of the group. Other positive contributions came from our holdings in DS Smith, Rentokil, Domino Printing Sciences, Howden Joinery and Burberry Group. Activity over the month included new purchases in BT Group and Bodycote and additions to our holdings in Diageo, AstraZeneca and DS Smith. We reduced our positions in Royal Dutch Shell, GlaxoSmithKline and Wolseley and sold out of Reckitt Benckiser, Burberry Group and Shire. Eurozone economic activity is showing signs of improvement as the European Central Bank starts quantitative easing, whilst in the US the ending of quantitative easing is contributing to uncertainty. We continue to focus more on the specific drivers of individual companies and the ability to determine their future rather than relying on a specific macro outcome. Given the outlook for both economic growth and interest rates remains uncertain, we seek those companies that can drive returns through self-help and have a clear strategy to deploy the cashflow they generate. The portfolio is primarily invested in high free cash flow companies that can sustain cash generation and pay a growing dividend yield, but also has exposure to companies with sustainable growth franchises and turnaround situations. * NAV - Inc. performance. 17 March 2015
UK 100

Latest directors dealings